Drug Discovery Turns Fatal: Chennai based pharmacist dies after consuming experimental drug

Published On 2020-05-08 15:58 GMT   |   Update On 2020-05-09 05:08 GMT
Advertisement

Chennai:  In a tragic incident where a drug discovery turned fatal, a senior official of the city-based Sujatha Bio-Tech died after consuming a drug purportedly for controlling blood pressure, police said on Friday

"Sivanesan, 47, was working with Sujatha Bio-Tech. As per the company officials and his wife, Sivanesan was said to be working on a drug to control blood pressure," M.C. Ramesh, Inspector of Police at Teynampet Station, told IANS.

Advertisement

Ramesh said as per the complaint, Sivanesan gave the new drug to company founder Rajkumar who took it in small quantities and fainted.

On the other hand Sivanesan took a larger dose and fainted too and later died.

Ramesh said post mortem will be done after tests for Coronavirus infection is done, which is the practice now.

Sujatha Bio Tech is known for its cough syrup in sachet Nivaran, Velvette Shampoo and Memory Plus tablet. It is a 30 year old company it specialises in producing Ayurvedic and herbal products company.

Many media reports have claimed that the 47 year old pharmacist was attempting to make a drug for coronavirus. However, citing news reports that said the new drug was for Coronavirus cure, police said it is not known how the background got changed.


Tags:    
Article Source : with inputs from ians

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News